Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

University of Cincinnati Announces Microfluidic Breakthroughs

Published: Wednesday, October 31, 2012
Last Updated: Wednesday, October 31, 2012
Bookmark and Share
Using something called “inertial microfluidics,” scientists are able to continuously and selectively collect rare cells, such as circulating tumor cells, based on their size vs. other biomarkers.

This method could reduce analysis time and increase selectivity while reducing reliance on antibody-based testing in clinical tests.

Ian Papautsky, associate professor in UC’s School of Electronic and Computing Systems (SECS), part of the College of Engineering and Applied Science, and a UC team are leading these research efforts.

In a paper titled “Continuous Rare Cell Extraction Using Self-Releasing Vortex in an Inertial Microfluidic Device” by Papautsky and co-authors Xiao Wang, UC doctoral student, and Jian Zhou, research associate, a new concept for separation of rare cells, such as prostate cancer cells or circulating tumor cells, using microfluidics, is detailed.

“Last year we showed we can selectively isolate prostate cancer cells, but only by running small sample volumes one at a time. Now we show that we can do this continuously,” Papautsky said. “This is exciting because it allows for an entire blood draw to be processed, in continuous matter, in a shorter period of time.”

These blood draws can be used to identify tumor cells for diagnostic or prognostic purposes. “Our approach is based purely on size. It doesn't rely on antibodies, which is important because not all cancer cells express antigens. So, if the cancer cells are, let's say, larger than 20 microns, we'll extract them,” he explained.

The most common approach for looking for these circulating tumor cells is via a system that uses a selection using antibodies to detect antigens. “We could also use our device to prepare samples for systems that use antibody-based selection.” This combined approach could potentially help reduce occurrence of false positives while significantly increasing the accuracy of the antibody-based tests.

Another area in which this device could be useful is in working with cell cultures. “If you have a mixture of multiple cells where some cells are small and other cells are big, we could separate these cell populations very easily,” Papautsky explained. “Anytime you need to separate based on size, we can do it using inertial microfluidics.”

The advantage of inertial microfluidics in cell separation is that it can be done easily and without cumbersome equipment. This research is leading to an entirely new generation of testing capabilities which particularly lend themselves to direct use in the field and in physicians’ offices in just about any country and any economic setting.

In another paper, titled “Sorting of Blood in Spiral Microchannels” Papautsky and doctoral student Nivedita Nivedita demonstrate continuous sorting of blood utilizing inertial microfluidics via a simple passive microfluidic device. Papautsky’s lab has been developing the concept of using inertia to manipulate cells and particles during the last few years. “It's truly different and innovative because these microfluidic devices are really low cost while offering very high throughput,” said Papautsky.

The device is, essentially, a clear, plastic, flexible square that is relatively small in size, at about a half an inch across, but big in concept. “With this particular device we can take a drop of blood, put it in the input port in the center, and separate,” Papautsky explained. The device contains four outlet ports which separate the blood into different streams, allowing the collection of outputs containing dilute plasma, red blood cells and white blood cells.

“There are a lot of clinical diagnostic tests that are based on blood,” he said. One of the most common tests that are done in a hospital is the complete blood count (CBC). Through this test, a wide range of conditions like anemia, malaria or leukemia are diagnosed. “In all of these diagnostic tests, blood must be separated into its components, and that's what this device does,” Papautsky explained. “So, instead of using a big centrifuge to do it, we can do it with this little device.” Using the microfluidic device allows for a diagnosis in less time in a much easier fashion.

This quick, low-cost way of running a diagnostic test could potentially be used in a resource-limited setting. “One of the issues that I hear from my colleagues who work in these areas that do tests is that they have equipment,” he said, “but don't always have personnel or stable power to operate them. So in places like India, Africa or Central America, our devices could be useful.”

This work was supported by the DARPA Micro/Nano Fluidics Fundamentals Focus (MF3) Center at the University of California at Irvine.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

'Wimpy' Antibody Protects Against Kidney Disease in Mice
Study finds that the mouse antibody IgG1 may actually be protective.
Tuesday, November 04, 2014
Hello? Sweat and a Smartphone Could Become The Hot New Health Screening
A new article highlighting UC research reveals how sweat and microfluidics can pinpoint and help dodge potential health issues for everyone from athletes to preemies.
Tuesday, October 28, 2014
UC Develops Unique Nano Carrier to Target Drug Delivery to Cancer Cells
Researchers have developed a unique nanostructure that can, because of its dual-surface structure, serve as an improved “all-in-one tool” against cancer.
Thursday, October 31, 2013
Biomarkers Discovered for Inflammatory Bowel Disease
Researchers have identified a number of biomarkers for inflammatory bowel disease (IBD), which could help with earlier diagnosis and intervention.
Thursday, May 23, 2013
Patient Openness to Research Can Depend on Race and Sex of Study Personnel
Researchers have found that the race and sex of study personnel can influence a patient’s decision on whether or not to participate in clinical research.
Monday, May 20, 2013
Researchers Solve Crystal Structure of Key Biofilm Protein
Scientists have solved the crystal structure of a protein involved in holding bacterial cells together in a biofilm, a major development in their exploration of the causes of hospital-acquired infections.
Monday, January 28, 2013
Researchers Discover Gene That Causes Deafness
University of Cincinnati scientists have found a new genetic mutation responsible for deafness and hearing loss associated with Usher syndrome type 1.
Wednesday, October 03, 2012
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Self-Assembling, Biomimetic Membranes May Aid Water Filtration
A synthetic membrane that self assembles and is easily produced may lead to better gas separation, water purification, drug delivery and DNA recognition, according to an international team of researchers.
Researchers Discover Immune System’s 'Trojan Horse'
Oxford University researchers have found that human cells use viruses as Trojan horses, transporting a messenger that encourages the immune system to fight the very virus that carries it.
Crystal Clear Images Uncover Secrets of Hormone Receptors
NIH researchers gain better understanding of how neuropeptide hormones trigger chemical reactions in cells.
How Cholesterol Leads to Clogged Arteries
A new study shows that when immune cells called neutrophils are exposed to cholesterol crystals, they release large extracellular web-like structures that trigger the production of inflammatory molecules linked to artherosclerosis.
Genetic Tug of War
Researchers have reported on a version of genetic parental control in mice that is more targeted, and subtle than canonical imprinting.
Ultrafast DNA Diagnostics
New technology developed by UC Berkeley bioengineers promises to make a workhorse lab tool cheaper, more portable and many times faster by accelerating the heating and cooling of genetic samples with the switch of a light.
Researchers Discover New Type of Mycovirus
Virus infects the fungus Aspergillus fumigatus, which can cause the human disease aspergillosis.
Error Correction Mechanism in Cell Division
Cell biologists have reported an advance in understanding the workings of an error correction mechanism that helps cells detect and correct mistakes in cell division early enough to prevent chromosome mis-segregation and aneuploidy, that is, having too many or too few chromosomes.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!